Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1988 2
1989 1
1990 3
1991 2
1992 6
1993 5
1994 4
1995 1
1996 7
1997 7
1998 9
1999 7
2000 7
2001 4
2002 6
2003 4
2004 5
2005 10
2006 10
2007 7
2008 11
2009 11
2010 6
2011 9
2012 8
2013 8
2014 4
2015 8
2016 11
2017 7
2018 11
2019 8
2020 6
2021 1
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
PD-L1 status in breast cancer: Current view and perspectives.
Vranic S, Cyprian FS, Gatalica Z, Palazzo J. Vranic S, et al. Among authors: palazzo j. Semin Cancer Biol. 2021 Jul;72:146-154. doi: 10.1016/j.semcancer.2019.12.003. Epub 2019 Dec 26. Semin Cancer Biol. 2021. PMID: 31883913 Review.
Supervised risk predictor of breast cancer based on intrinsic subtypes.
Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS. Parker JS, et al. Among authors: palazzo j. J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204204 Free PMC article. Corrected and republished.
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes.
Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS. Parker JS, et al. Among authors: palazzo j. J Clin Oncol. 2023 Sep 10;41(26):4192-4199. doi: 10.1200/JCO.22.02511. J Clin Oncol. 2023. PMID: 37672882
The Spectrum of Mucinous Lesions of the Breast.
Joneja U, Palazzo J. Joneja U, et al. Among authors: palazzo j. Arch Pathol Lab Med. 2023 Jan 1;147(1):19-29. doi: 10.5858/arpa.2022-0054-RA. Arch Pathol Lab Med. 2023. PMID: 36577093 Free article. Review.
High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer.
Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP, Rui H. Chervoneva I, et al. Among authors: palazzo jp. JCO Precis Oncol. 2023 Jan;7:e2100498. doi: 10.1200/PO.21.00498. JCO Precis Oncol. 2023. PMID: 36652667 Free PMC article.
Consensus conference on breast conservation.
Schwartz GF, Veronesi U, Clough KB, Dixon JM, Fentiman IS, Heywang-Köbrunner SH, Holland R, Hughes KS, Mansel RE, Margolese R, Mendelson EB, Olivotto IA, Palazzo JP, Solin LJ; Consensus Conference Committee. Schwartz GF, et al. Among authors: palazzo jp. J Am Coll Surg. 2006 Aug;203(2):198-207. doi: 10.1016/j.jamcollsurg.2006.04.009. J Am Coll Surg. 2006. PMID: 16864033 No abstract available.
Pathologic Spectrum of Secretory and Mucinous Breast Lesions.
Toll A, Joneja U, Palazzo J. Toll A, et al. Among authors: palazzo j. Arch Pathol Lab Med. 2016 Jul;140(7):644-50. doi: 10.5858/arpa.2015-0250-RA. Arch Pathol Lab Med. 2016. PMID: 27362569 Free article. Review.
207 results